Opinion: CDC should lead fight against fake TB meds

The CDC is best suited to spearhead efforts in combating fraudulent and substandard tuberculosis treatments, American Enterprise Institute resident scholar Roger Bate writes. The agency should collaborate with the World Bank and the State Department's Office of Global Health Diplomacy to help drugmakers, governments and law enforcement curb the production of substandard treatments and fortify drug supply chains, Bate writes. Furthermore, producers of deadly counterfeits should be prosecuted.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief: